抗苗勒管激素的相关影响因素研究进展(2)

但是IR是否与AMH相关以及如何与AMH产生关联尚未明确。另外，关于雌激素水平、血糖水平等可能影响AMH的相关因素，研究较为缺乏。

总之，已有的研究表明，AMH水平受到月经周期、药物使用、机体疾病状态等因素的影响，还有可能受到中枢性腺

轴的间接调控。在使用AMH评估卵巢储备和反应性时需结合患者的实际情况综合分析，才能准确地体现其预测价值。

参考文献

[1]

KarkanakisignificanceA,gynecologicalofVosnakisanti-MullerianC,PanidishormoneD.evaluationTheclinical

in[2]

(2):95endocrinology[J].Hormones(Athens),2011,10Robeva-103.

antiR,MekhandzhievT,Tomovaclinical-mullerianA,etal.The[3]

50practice[J].hormone:physiologyandapplicationintoJeppesen-54.

AkushGinekol(Sofiia),2006,45(7):folliclesJV,AndersonRA,KelseyTW,Evidencemakethemostanti-Mullerianhormoneetinal.humans?Whichtime[4]519offollicleforanselection[J].abruptdeclineMolinAMHproductionattheDewailly-527.

HumReprod,2013,19(8):clinicalD,AndersenCY,BalenA,et[5]Reprodutilityofanti-Mullerianhormoneal.Theinwomen[J].physiologyandKelseyserumTW,Update,Wright2014,P,20(3):370NelsonSM,-385.

Humet[6]

[J].anti-mullerianhormonefromconceptional.AvalidatedtomenopausemodelofLeonhardtPLoSOne,assessedH,Hellstrom2011,6(7):e22024.

M,GullB,etal.Ovarianwithoutantimullerianpolycysticbymagneticovaryresonancesyndromeimaginginwomenmorphologywithand[7]

disposalHansenrate[J].hormone,FertilSteril,free2014,testosterone,andassociationsandglucosewithovarianKR,HodnettGM,Knowlton101(6):1747N,etal.-Correlation1756.

ofprimordialreserve[8]170Kelsey-175.

follicletestsnumber[J].withFertilhistologicallySteril,2011,determined95(1):assessmentTW,AndersonRA,WrightP,etal.Data-driven[9]Reprod,ofthehumanovarianreserve[J].MolHumNelson2012,AntiSM,18(2):79-87.

[10]

Hum-MullerianAndersonhormone:clairvoyanceRA,BroekmansorcrystalFJ,clear?[J].etal.vaninterDisseldorpReprod,2012,J,Lambalk27(3):631CB,-636.

KweeJ,parisonof[11]

221antralfolliclecounts[J].HumReprod,2010,hormone25(1):Hadlow-227.

antimullerianN,LonghurstcyclehormoneK,concentrationMcClementsA,duringetal.theVariationmenstrualin[12]

response[J].maychangeKissellFertilSteril,theclinical2013,99(6):1791classificationoftheovarianvariabilityKA,menstrualincycleinDanaherserumMR,SchistermanEF,-1797.

etal.Biologicalinovulatoryanti-Mullerianandsporadichormoneanovulatorythroughoutcyclesthe[13]1764eumenorrheicwomen[J].HumReprod,2014,29(8):Bottcher-1772.

anti-MullerianB,TsybulyakhormoneI,duringGrubingercontrolledT,etovarianal.Dynamicsstimulationof[14][J].FanchinGynecolantiR,Endocrinol,Schonauer2014,LM,30(2):121Righini-125.

C,et[15]

hyperstimulation[J].-MullerianhormoneFanchinR,MendezHumdynamicsal.SerumLD,LouafiReprod,N,2003,duringcontrolledovarianetal.18(2):328Dynamics-332.

ofserum

anticontrolled-Mullerianhormonelevelsduringthelutealphase[16]

20(3):747ovarianhyperstimulation[J].HumReprod,2005,ofGrigoryan-751.

metforminofGinecol,polycysticonO,theAbsatarovaJ,AndreevaE,etal.Effectofovarylevelsyndromeofanti-Mullerianinobesehormonewomen[J].inMinervatherapy[17]NeagumarkerM,2014,Cristescu66(1):85C.-Anti89.

-Mullerianhormone:aprognosticwomenfor[18]

Medwithmetformininfertilitytherapyandpolycysticefficiencyovaryinthesyndrome[J].treatmentofNascimentoLife,2012,AC,AD,5(4):462SilvaLara-464.

JLA,JapurdeSáRosaantipatients-Mullerianetal.Effectshormoneoflevelsmetforminandononhyperandrogenismseruminsulin-e-Silvaandin[19]

Endocrinol,withKristensen2013,polycysticovarysyndrome[J].GynecolassociationSL,hormonebetweenRamlau29(3):246-Hansen-249.

CH,AndersenCY,etal.Thecharacteristicsandfollicle[20]

779inyoungnumber,circulatinglevelsofantimullerianwomen[J].androgens,FertilandSteril,menstrual2012,97(3):cyclePanidis-785.

oralD,GeorgopoulosNA,PioukaA,etal.Theserumcontraceptivesbiochemicallevelsinwomenandmetforminonanti-Mullerianimpacthormoneof[21]

2011,hyperandrogenemia[J].withpolycysticGynecolovarysyndromeandKallio27(8):587hormoneS,Puurunen-592.

Endocrinol,contraceptionlevelsJ,RuokonenA,etal.Antimullerian[22]Steril,independentlydecreaseofinwomenusingcombinedTranhormoneND,2013,Cedars99(5):1305MI,Rosen-1310.

administrationroute[J].FertilMP.Therole[23]

Endocrinol(AMH)ChanMetab,inofanti-mullerian2011,assessingovarianreserve[J].JClinidiopathicC,LiuutilityhypogonadotropicK.Clinical96(12):3609pregnancy-3614.

hypogonadisminawomanwith[24]Genet,ofKalampokas2014,ovarian31(10):1317reservemarkersinIHH[J].andJAssistlowReprodAMH:laparoscopicT,[25]

Endocrinol,surgeryKamath-1321.

oftheMS,ovaries:KalampokasaE.AMHafterSkalbaantiP,2013,Cygal29(5):408A,Madej-411.

review[J].GynecolP,etal.weight-Mullerianwithandmetabolic,hormoneand(AMH)levelassociatedIsthewithplasmabody[26]GynecolandCuihormoneY,ShiReprodwithoutY,CuiBiol,polycystichormonalovarysyndrome?[J].disturbancesEurinJwomenObstetL,2011,etal.158(2):254Age-specific-259.

serum[27]

syndrome[J].levelsPiltonenFertilinwomenSteril,2014,with102(1):230andwithoutpolycysticantimullerianovaryantireproductive-MullerianT,Morin-PapunenL,Koivunen-236.

R,etal.Serumwomen[28]2005,withagehormoneanddecreaselevelsduringremainmetforminhighuntiltherapylatein肖(AMH)琳,20(7):1820polycystic李启富,唐-1826.

ovarysyndrome[J].HumReprod,良萏.PCOS患者血清抗苗勒管激素[29]

孕Seow,2011,水平与胰岛素抵抗及雄激素的关系predictionKM,31(7):488[J].生殖与避WangPH.-490.

Antimullerianhormone:[J].JChinMedofovarianAssoc,function2012,andpolycysticovaryamarkersyndromefor（75(3):93收稿日期：-94.

2014-11-11）

（本文编辑：沈平虎）

抗苗勒管激素的相关影响因素研究进展

作者：作者单位：刊名：英文刊名：年，卷(期)：

刘曼琳， 杨冬梓

中山大学孙逸仙纪念医院妇产科生殖中心,广州,510120中华妇产科杂志

Chinese Journal of Obstetrics and Gynecology2015(5)

引用本文格式：刘曼琳.杨冬梓 抗苗勒管激素的相关影响因素研究进展[期刊论文]-中华妇产科杂志 2015(5)